Kong Ruirui, Chen Jing, Zhao Feilong, Li Yan, Yang Huiyi, Zheng Yudong, He Wei
School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, China.
Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
Int J Biol Macromol. 2024 Dec;283(Pt 3):137598. doi: 10.1016/j.ijbiomac.2024.137598. Epub 2024 Nov 17.
Angiogenesis-osteogenesis coupling plays important roles in bone regeneration; therefore, biomaterials capable of stimulating both osteogenesis and angiogenesis show significant influence in bone repair. Herein, chitosan (CS) microcarriers loaded with functional drug dimethyloxalylglycine (DMOG) were prepared using the emulsion phase separation and impregnation method for stimulating osteogenesis and angiogenesis. FTIR and zeta potential analyses confirmed successful DMOG loading into CS microcarriers, primarily through physical adsorption, particularly hydrogen-bond interaction. As the impregnation concentration of DMOG increased, the amounts of DMOG loaded into the microcarriers increased, while the drug encapsulation efficiency decreased. All microcarriers, ranging in size from 200 to 400 μm, revealed quasi-spherical shapes and an interconnected porous structure with pore sizes mainly between 15 and 30 μm, suitable for cell attachment and proliferation. The introduction of DMOG increased the residues of the microcarriers during thermogravimetric analysis. CS/DMOG microcarriers exhibited sustained drug release (for >19 days) and good degradation ability. Furthermore, CS/DMOG microcarriers supported stem cell adhesion and proliferation. They also enhanced stem cell osteogenesis verified by strengthening alkaline phosphatase expression and mineralization. Moreover, they promoted angiogenesis, as evidenced by stimulating endothelial cell migration and tube formation. These results suggest that CS/DMOG microcarriers have the potential to be used for bone tissue regeneration.
血管生成 - 骨生成耦合在骨再生中发挥着重要作用;因此,能够同时刺激骨生成和血管生成的生物材料在骨修复中具有显著影响。在此,采用乳液相分离和浸渍法制备了负载功能性药物二甲基草酰甘氨酸(DMOG)的壳聚糖(CS)微载体,以刺激骨生成和血管生成。傅里叶变换红外光谱(FTIR)和zeta电位分析证实DMOG成功负载到CS微载体中,主要通过物理吸附,特别是氢键相互作用。随着DMOG浸渍浓度的增加,负载到微载体中的DMOG量增加,而药物包封效率降低。所有微载体尺寸在200至400μm之间,呈现准球形形状和相互连接的多孔结构,孔径主要在15至30μm之间,适合细胞附着和增殖。DMOG的引入增加了热重分析过程中微载体的残留量。CS/DMOG微载体表现出持续的药物释放(超过19天)和良好的降解能力。此外,CS/DMOG微载体支持干细胞黏附和增殖。通过增强碱性磷酸酶表达和矿化也证实它们增强了干细胞的成骨能力。而且,它们促进血管生成,这通过刺激内皮细胞迁移和管腔形成得以证明。这些结果表明CS/DMOG微载体具有用于骨组织再生的潜力。